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The prokaryotic clusters of regularly interspaced
palindromic repeats (CRISPR) system utilizes ge-
nomically encoded CRISPR RNA (crRNA), derived
from invading viruses and incorporated into ribonu-
cleoprotein complexes with CRISPR-associated
(CAS) proteins, to target and degrade viral DNA or
RNA on subsequent infection. RNA is targeted by
the CMR complex. In Sulfolobus solfataricus, this
complex is composed of seven CAS protein subunits
(Cmr1-7) and carries a diverse ‘‘payload’’ of targeting
crRNA. The crystal structure of Cmr7 and low-resolu-
tion structure of the complex are presented.
S. solfataricus CMR cleaves RNA targets in an endo-
nucleolytic reaction at UA dinucleotides. This activity
is dependent on the 8 nt repeat-derived 50 sequence
in the crRNA, but not on the presence of a proto-
spacer-associated motif (PAM) in the target. Both
target and guide RNAs can be cleaved, although a
single molecule of guide RNA can support the degra-
dation of multiple targets.
INTRODUCTION
The CRISPR system has recently come to light as a complex
mechanism of cell-mediated antiviral immunity (see Horvath
and Barrangou, 2010; Karginov and Hannon, 2010; Marraffini
and Sontheimer, 2010a for recent reviews). CRISPRs are ge-
nomically encoded arrays of short ‘‘spacer’’ sequences (20–
72 bp, depending on the species), each flanked by a repeat
sequence with an average length around 25–30 nt. CRISPR
arrays are transcribed by the cellular RNA polymerase and
processed to generate small crRNAs by nucleolytic cleavage
within the repeat sequences (Brouns et al., 2008; Carte et al.,
2008; Deltcheva et al., 2011). Processed crRNAs are utilized
by a variety of CRISPR-associated (CAS) protein complexes
as a guide RNA to target (and degrade the nucleic acid of)Moleinvading genetic entities with complementary nucleic acid
sequences. This defensive ‘‘interference’’ process works in
tandem with an adaptive ‘‘capture’’ process that allows the
incorporation of new spacer sequences derived from viruses
into the genomic CRISPR arrays.
The viral DNA sequences that become incorporated into
CRISPR arrays are known as ‘‘protospacers’’ (Horvath et al.,
2008). Protospacers are derived from both coding and noncod-
ing regions of viral genomes, suggesting that the viral DNA,
rather than RNA, is targeted by the process that captures new
spacers (Horvath et al., 2008; Shah et al., 2009). Examination
of the sequence context of protospacers revealed the presence
of a conserved ‘‘protospacer-associated motif’’ (PAM) consist-
ing of a di- or trinucleotide signature, immediately adjacent to
the protospacer sequence (Bolotin et al., 2005; Deveau et al.,
2008; Horvath et al., 2008; Mojica et al., 2009). The presence
of a PAM is important for the recognition and restriction of
invading mobile DNA elements (Deveau et al., 2008; Gudbergs-
dottir et al., 2011).
CAS protein complexes have recently been classified into
three main subtypes (Makarova et al., 2011b). In Escherichia
coli, the type I-E complex, commonly known as ‘‘CASCADE,’’
consists of five protein subunits (CasA-E). CASCADE processes
CRISPR transcripts into57 nt crRNAs and uses them to recog-
nize invading viral DNA, which is subsequently cleaved by Cas3
(Brouns et al., 2008). A similar complex (type I-A) with several
conserved subunits has been described in Sulfolobus solfatari-
cus (Lintner et al., 2011). Many archaea and some bacteria
also encode a type III-B system, known as the CMR complex
(Haft et al., 2005). In the euryarchaeon Pyrococcus furiosus,
the Cmr1-6 proteins have been purified as a complex that uses
crRNA to target RNA (presumably viral mRNA in vivo), cleaving
it with a molecular ruler mechanism guided by the 30 end of the
crRNA (Hale et al., 2009).
Here, we report the purification and characterization of the
CMR complex from S. solfataricus. There are seven subunits,
comprising Cmr1-7 and a crRNA component. Deep sequencing
reveals a biased composition for the crRNA, which is largely
derived from 2 of the 6 CRISPR loci. The crystal structure of
the Cmr7 subunit has been solved and consists of a protein
fold with a conserved surface that may mediate molecularcular Cell 45, 303–313, February 10, 2012 ª2012 Elsevier Inc. 303
Figure 1. Purification of the CMR Complex of
S. solfataricus
(A) UV trace showing fractions eluting from final MonoQ
column, with CMR and RNAP complexes resolved.
(B) SDS-PAGE analysis of fractions from MonoQ column,
showing separation of RNAP (fraction 30) from the
7-subunit CMR complex.
(C) Denaturing gel electrophoresis of end-labeled nucleic
acid reveals the presence of RNA copurifying with the
CMR complex. The size range centered on 46 nt corre-
sponds to a spacer with an 8 nt repeat-derived 50 tag.
(D) Comparison of native and tagged versions of the CMR
complex purified from S. solfataricus. Both tagged and
untagged versions of Cmr7 are apparent, reflecting its
higher stoichiometry in the complex.
(E) Mapping of Cmr1–7 onto the gene locus sso1986 to
sso1992.
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a defined subcomplex are presented. We demonstrate that
S. solfataricus CMR (SsoCMR) utilizes a sequence-dependent
RNA cleavage mechanism without a molecular ruler.
RESULTS
Purification of the CMR Complex from S. solfataricus
The native CMR complex was purified from S. solfataricus using
four sequential column chromatography steps (heparin, gel
filtration, MonoS, and MonoQ). At each stage, column fractions
were checked for the presence of the Cmr7 subunit by ‘‘dot
blot’’ with a specific polyclonal antibody. SsoCMR copurified
with the cellular RNA polymerase through the first three columns
and was separated by the final anion exchange step (Figure 1A).
The purified complex contained seven subunits corresponding
to the products of genes sso1986 through sso1992. Subunits
1–6 were judged present at a 1:1 stoichiometry; densitometric
analysis suggested that the Cmr7 subunit was present at a stoi-
chiometry of three dimers in each complex (Figures 1 and S1).
This was consistent with an overall size for the complex of
415 kDa (or 430 kDa including the RNA component), explaining
the copurification on gel filtration with the 410 kDa RNA poly-
merase. The presence of RNA, with a variable fragment size
centered on 46 nt, was confirmed (Figure 1C). This was in
good agreement with the size of the crRNA species isolated
from P. furiosus CMR (PfuCMR) (Hale et al., 2009), consistent
with the presence of a spacer sequence of variable length with
a CRISPR repeat-derived 8 nt tag at the 50 end. By expressing304 Molecular Cell 45, 303–313, February 10, 2012 ª2012 Elsevier Inc.subunits (Cmr7 or Cmr3) of SsoCMR with a
polyhistidine tag in S. solfataricus, the intact
complex could be isolated by incorporating an
affinity chromatography step (Figure 1D).
RNA Content of the CMR Complex
To determine the specific characteristics of
the RNA component of SsoCMR, isolated
RNA was cloned and deep-sequenced. We
mapped 1.88 million sequence reads of 36 ntlength onto the S. solfataricus spacers (Table S1). Analysis of
the start and stop positions of the sequence reads for a subset
of highly represented spacers from the A and D loci revealed
the presence of sequence corresponding to the 50 tag derived
from the CRISPR repeat, with a clear demarcation at the eighth
nucleotide, which corresponds to the site of cleavage by
Cas6 (Carte et al., 2008; Lintner et al., 2011) (Figure S2). The 30
ends of the sequenced RNA were more variable. Some spacers
such as A2 and D43 displayed a short 30 handle, while others
appeared to have very little repeat-derived sequence at the 30
end. Overall, this fits the suggestion that crRNA is processed
by the Cas6 endoribonuclease followed by exonucleolytic
digestion of the 30 end (Hale et al., 2009). By contrast, crRNA
isolated from the S. solfataricusCASCADE complex still includes
the 30 repeat-derived sequence (Lintner et al., 2011), suggesting
that crRNAs are differentially processed depending on their
ultimate destination in CASCADE or CMR.
S. solfataricus P2 has six CRISPR loci, denoted A–F, ranging
from 8 to 103 repeats in length (Lillestøl et al., 2006). Whole-
genome transcription data suggested that loci A, B, C, and D
are all highly transcribed, while E and F are very weakly tran-
scribed (Wurtzel et al., 2010). Examples of spacers derived
from all six loci were detected in the CMR complex, but the
distribution was highly biased. The majority of CMR-bound
crRNAs were derived from locus D, followed by locus C, with
significant underrepresentation from the other four loci (Fig-
ure 2). Within a locus, spacer representation in the CMR com-
plex was highly variable, with numbers of sequenced crRNAs
from adjacent spacers frequently differing by several orders of
Figure 2. Distribution of crRNA Bound by the S. solfataricus CMR Complex
(A–F) Examples of crRNAs from all six CRISPR loci were observed, with a clear bias toward locus D, followed by locus C. The individual plots for each locus show
that crRNA representation was highly variable, with adjacent spacers represented at levels that often varied by several orders of magnitude. For each graph, the x
axis represents the position of each spacer in the locus and the y axis represents the number of sequenced matches to each spacer. 88% of the total sequence
reads were derived from locus D, which represents a nearly 4-fold overrepresentation compared to the proportion of crRNAs encoded by that locus. CRISPR loci
E and F, which are poorly transcribed, were significantly underrepresented, as expected. However, crRNAs from CRISPRs A and B, which are highly transcribed
and thought to be actively adding spacers in vivo, are also significantly underrepresented in the CMR complex. The table shows the properties and representation
in CMR of each CRISPR locus.
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for 45% of the sequence reads, and the top ten spacers ac-
counted for 79% of the total reads mapped to spacers (Table
S2). Reverse transcripts of CRISPR arrays have been detected
in Sulfolobus species (Lillestøl et al., 2009), but their signifi-
cance remains unclear. Only 209 RNAs corresponding to
reverse transcripts were sequenced, corresponding to 0.01%
of the total (Table S1).MoleThe Crystal Structure of Cmr7
The crystal structure of Cmr7 (Sso1986) was solved to 2.05 A˚
resolution (PDB 2X5Q) (Figure 3). Sso1986 exhibits a fold con-
sisting of six b sheets and four a helices, forming a dimer with
a buried surface area of 1177 A˚2 and a concave face (Figures 3
and S3A). Homologs of Cmr7 are only detectable in the
Sulfolobales, but given the rapid evolution of the CRISPR
system, it is possible that distant homologs sharing this fold existcular Cell 45, 303–313, February 10, 2012 ª2012 Elsevier Inc. 305
Figure 3. Crystal Structures of Two Members of the Cmr7 Family,
Viewed from the Concave Face of the Dimer
(A) The Cmr7 proteins Sso1986 (left) and Sso1725 (right) contain a structurally
conserved core (yellow) and a variable region (blue and cyan for Sso1986 and
Sso1725, respectively). The b13-b14 loop of Sso1986 is disordered and is
represented as a dashed, black line. The N and C termini are represented as
blue and red spheres, respectively.
(B) Sso1986 and Sso1725 both form dimers, and the structurally conserved
core is located at the dimer interface. The interface itself is also conserved
between the two proteins.
(C) The structurally conserved residues (green) and secondary structure
(yellow) are located close to the dimer interface with a significant proportion
positioned at the concave face.
(D) Electrostatic surface images show that the regions of the concave face
proximal to the dimer interface in both proteins (black box) have broad
similarities.
Table 1. Data Collection and Refinement Statistics for Sso1725
Data collection Native Anomalous
Wavelength (A˚) 0.97 1.60
Space group P212121 P212121
a, b, c (A˚) 77.75, 90.29, 111.65 77.71, 91.08, 111.94
a, b, g () 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Resolution (A˚) 47.48–2.08
(2.13–2.08)
77.11–2.54
(2.61–2.54)
I/sI 19.2 (2.2) 20.7 (2.8)
Rmerge 0.04 (0.57) 0.06 (0.71)
Completeness 97.8 (86.1) 99.9 (99.8)
Multiplicity 4.7 (3.7) 7.8 (7.9)
Anomalous completeness - 99.9 (99.7)
Anomalous multiplicity - 4.1 (4.1)
Refinement Sso1725
Rwork/Rfree 0.199/0.231
Mean B value (A˚2)
All atoms 59.442
Protein 59.481
Water 54.758
Root-mean-square deviations
Bond lengths (A˚) 0.01
Angles () 1.31
Each data set was collected on a single crystal at 100 K. Statistics are
presented as averages with values for the highest-resolution shell in
parentheses. Rfree was calculated from a random 5% of the reflection
data that was omitted from the subsequent refinement.
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Cmr7, we solved the structure of a second Cmr7 subunit,
Sso1725. The sequence similarity between the two proteins is
low (19% identity), and the crystal structure of Sso1725 (solved
to 2.08 A˚ resolution; Table 1) shows limited structural similarity
(Ca rmsd of 2.39 A˚ over 121 atoms for each monomer). The
majority of the residues conserved in the six known orthologs
of Cmr7 are located in the dimer interface and concave face
(Figures 3C and S3). The electrostatic surfaces of the two
proteins show broad similarities at the dimer interface, with
symmetrical patches of negative charge at the poles and positive
charge at the edges (Figure 3D). Given this level of conservation
on only one face of the protein, we hypothesize that this region is
important for function, possibly as a binding site for other CMR306 Molecular Cell 45, 303–313, February 10, 2012 ª2012 Elsevier Insubunits. The stoichiometry of three dimers of Cmr7 per CMR
complex is most easily accommodated if they form a trimeric
(pseudo-hexamer) structure in the context of the complex.Electron Microscopy Reveals the Architecture of the
CMR Complex
To elucidate the three-dimensional architecture of the CMR
complex, we performed electron microscopy coupled to
single-particle analysis experiments for the full complex and
additionally for Cmr2/Cmr3/Cmr7 subcomplex, devoid of RNA
(Figures 4 and S4). Projections of the maps matched with 2D
averages assigned the same Euler angles (Figure S4), high-
lighting the validity of the maps. The resolution for both maps
was 25 A˚, calculated at 0.5 Fourier Shell Correlation (3 sigma).
The CMR complex exhibited cavities, compatible with an RNA
threading machine. There was no obvious similarity to the ‘‘sea-
horse’’ structure of E. coli CASCADE (Jore et al., 2011). The
Cmr2/Cmr3/Cmr7 subcomplex, which lacked bound crRNA,
hadoverall dimensions of 903 1203 110 A˚, organized in a clamp
or ‘‘crab claw’’ structure (Figure 4A). The intact CMR complex
with loaded crRNA had overall dimensions of 160 3 120 3
110 A˚ with an upper ‘‘crab claw’’ connected to a protruding
region (Figure 4B). These dimensions were compatible with the
expected molecular masses of 290 and 430 kDa, respec-
tively. The Cmr2/Cmr3/Cmr7 subcomplex fitted well to the upper
region of intact CMR (Figure 4C), consistent with a role asc.
Figure 4. 3D EM Visualization of CMR Complex
(A) Surface representation of the Cmr2/Cmr3/Cmr7 subcomplex devoid of
crRNA.
(B) Surface representation of the full CMR complex with bound crRNA.
(C) Superposition of Cmr2/Cmr3/Cmr7 (blue surface) on CMR/RNA (black
mesh). Black arrowheads point to regions of additional density on the full CMR
complex with bound crRNA compared to Cmr2/Cmr3/Cmr7. Gray arrows
indicate dimensions in angstroms.
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periphery (black arrows in Figure 4C).
Ribonuclease Activity of SsoCMR
We tested the ability of SsoCMR to recognize and cleave RNA
targets corresponding to spacers A1 and D63 in vitro. Both RNA
targets were cleaved efficiently when a cognate crRNA (guide
RNA) with an 8 nt 50 tag was present (Figure 5). Manganese ions
were essential for this activity, and magnesium could not substi-
tute. ATP was not essential, but clearly stimulated the cleavage
reaction (Figure S5). No crRNA-directed cleavage of DNA targets
was observed (data not shown). To rule out the possibility of
activity from a contaminating ribonuclease, the CMR complex
was immunodepleted using antibodies raised against the Cmr7
subunit. Immunodepletion abolished the nuclease activity, sug-
gesting strongly that the activity was associated with the CMR
complex (Figure S5A). As a further control, native untagged
SsoCMR purified from S. solfataricus cell extract by immunopre-
cipitation using the anti-Cmr7 antibody had the same activity as
the column-purified, tagged protein complex (Figure S5B).MoleFeatures of Guide and Target RNAs Important
for Cleavage by CMR
The sequence and structural requirements of RNA cleavage by
CMR were investigated by constructing a range of target and
guide RNA molecules based on the spacer A1 and D63
sequences. To test for a molecular ruler mechanism as observed
for PfuCMR, we reduced the length of the guide RNA (Figure 5A,
panel ii). The cleavage sites did not move in register with the 30
end of the guide RNA, suggesting that Sulfolobus and
Pyrococcus CMR differ fundamentally in this respect. Deletion
of the repeat-derived 50 tag from the guide RNA abolished
cleavage activity (Figure 5A, panel iii) and could not be rescued
by substitution with a 50 8A sequence (panel iv), showing that
this 50 tag sequence is essential for cleavage, ruling out the
possibility of a contaminating nuclease. The presence of an
unpaired flap at the 30 end of the target RNA was also required
for activity (panel vi). This corresponds to the position of the
PAM that is essential for cleavage of viral DNA targets by
CASCADE (Gudbergsdottir et al., 2011; Lintner et al., 2011).
However, for target RNA cleavage by CMR, the PAM sequence
at this position was not essential, as a 6A sequence could substi-
tute (Figure 5B, panel vii).
In addition to the target RNA, the guide RNA strand could also
be cleaved by SsoCMR (Figure 5C, panel viii). Cleavage of the
guide RNA was dependent on the presence of a 30 overhang
on the target RNA (Figure 5C, panel ix, xi). Guide and target
were cleaved at approximately equal rates when present at an
equimolar ratio, but at ratios of 20:1 or 5:1 excess of target
over guide, the guide RNAwas cleaved significantly more slowly.
Under these conditions, multiple turnover cleavage of the target
RNA was observed, suggesting that cleavage of the guide RNA
was not essential for catalysis (Figure S5D).
Sequence-Specific Cleavage by SsoCMR
The cleavage patterns observed for SsoCMR suggested a
sequence- or structure-specific component to the activity.
Sequence mapping suggested that strong cleavage always
occurred at a UA dinucleotide in both the A1 and D63 target
RNAs and the A1 guide RNA (Figure 5). Weaker cleavage was
observed at UU dinucleotides. RNA cleavage by SsoCMR re-
sulted in products with 30-hydroxyl termini that could be
extended by PolyA polymerase (Figure S6A). This is similar to
the metal-dependent RNaseH-type activity observed for Piwi
and Argonaute (Hutvagner and Simard, 2008). In contrast, the
(metal-independent) Cas6 endonuclease yields 30-cyclic phos-
phate products that are not extended by PolyA polymerase
(Figure S6B). PfuCMR is also reported to generate 30-cyclic
phosphate products (Hale et al., 2009), another distinction
between the two enzymes. To map the cleavage site of SsoCMR
precisely, the cleavage at site 2 in the D63 target RNA was
compared to a synthetic oligonucleotide terminating after the
relevant UA dinucleotide (Figure S6C). The cleavage product
generated by SsoCMRwas 1 nt shorter than the oligonucleotide,
consistent with cleavage at this position (and by extension at the
other sites) as occurring at the center of the UA sequence.
To examine the importance of sequence for CMR-mediated
cleavage of RNA, a D63-derived target RNA with only one
UA site, corresponding to position 2, was synthesized. In thecular Cell 45, 303–313, February 10, 2012 ª2012 Elsevier Inc. 307
Figure 5. Characterization of the S. solfataricus CMR Complex Activity In Vitro
(A)Radiolabeled targetRNA (5mM)corresponding to spacerA1was incubatedwith theCmr7-taggedSsoCMRcomplex (0.5mM)andguideRNA (1mM).Cleavageof
the targetRNAwasobserved at six sites (labeled 1–6) (i). 30 truncationof the guideRNAdidnot change the cleavagepattern of the targetRNA, rulingout amolecular
ruler mechanism (ii). The 8 nt 50 tag was essential for cleavage activity, as either deletion (iii) or replacement with an 8A sequence (iv) abolished nuclease activity.
(B) The D63 target (0.5 mM) was cleaved in the presence of Cmr7-tagged SsoCMR complex (0.5 mM), cognate guide RNA (0.1 mM) (v). Deletion of the unpaired
30 end of the target RNA, which corresponds to the position of the PAM sequence, abolished activity (vi). The presence of an unpaired 6A sequence at this position
restored activity (vii).
(C) Radiolabeled guide RNA corresponding to spacer A1 (3 mM) was incubated with the Cmr7-tagged SsoCMR complex (0.5 mM) and cognate target RNA (1 mM).
Cleavage was observed at up to five positions, labeled 20 to 60 (viii). This activity was dependent on the presence of the 30 unpaired spacer sequence (ix) and was
not influenced by the presence of an additional unpaired extension at the 30 end of the guide RNA (x, xi). For each figure part, the 50 end-labeled RNA strand is
indicated with an asterisk. Labeled decade RNA markers (Ambion) are shown.
Molecular Cell
CMR Complex for CRISPR-Mediated Antiviral Immunitypresence of the CMR complex and a cognate guide RNA
sequence, this target was cleaved strongly at position 2, with
only weak background cleavage elsewhere (Figure 6B). The308 Molecular Cell 45, 303–313, February 10, 2012 ª2012 Elsevier Insame reaction product was observed when pairing this target
with the wild-type guide, despite the presence of mismatches
at the mutated UA sites. A modified version of the D63 guidec.
Figure 6. The S. solfataricus CMR Complex
Cleaves RNA Selectively at UA Sites
(A) Sequence map of the D63 target and guide RNA.
(B) A D63 target oligonucleotide (D631UA, 0.5 mM) with UA
cleavage sites 1, 3, 4, and 5 mutated to UG, was labeled
and incubated with the Cmr3-tagged CMR complex
(0.5 mM) and a cognate guide RNA (crD631UA, 0.05 mM).
Cleavage of the target RNA was only observed at the
single remaining UA site, site 2. The same target paired
with the wild-type guide RNA gave identical cleavage
products despite the presence of three mismatches.
(C) A D63 guide RNA sequence with all four UA sites
mutated to CA (crD630UA, 0.5 mM) was labeled and incu-
bated with the Cmr3-tagged CMR complex (0.5 mM) and
a target RNA containing a single UA site at position 2
(D631UA, 0.05 mM). No significant cleavage of this target
sequence was observed. The standard guide RNA (crD63)
was cleaved at all four UA sites under the same conditions,
despite the presence of mismatches at three positions in
the RNA duplex. Control lanes for all gels are: m1, Ambion
Decade markers; c1, labeled RNA alone; c2, labeled RNA
and CMR; c3, both RNA strands without CMR. Asterisks
indicate the 50 RNA end labeled by 32P.
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ence of a target RNA with 1 UA site (Figure 6C). The presence of
mismatches in the guide RNA opposite the target cleavage site
did not abolish cleavage (Figure S6D), consistent with the
mismatch tolerance observed previously for CASCADE (Gud-
bergsdottir et al., 2011; Semenova et al., 2011). Overall, these
data confirmed that sequence-dependent cleavage of both the
guide and target RNAs is a defining feature of SsoCMR and
demonstrated that cleavage of the guide is not necessary for
cleavage of the target, consistent with the observation of
multiple turnover by the complex.
DISCUSSION
crRNA Content of SsoCMR
There are six CRISPR loci in S. solfataricus P2, named A–F
(Lillestøl et al., 2006). Deep sequencing of 1.88 million crRNAs
isolated from the CMR complex revealed a highly biased distri-
bution, with 98% of the total crRNAs derived from locus D and
C, an overrepresentation of 3.8- and 1.3-fold, respectively. The
underrepresentation of crRNAs from highly transcribed loci A
and B may be explained by differences in the processing of
repeats by Cas6. It is notable that the CRISPR repeat sequence
associated with the A and B loci is longer than those of C–F,
which could provide a plausible basis for differential processing
by Cas6. As S. solfataricus encodes five different Cas6 proteins,
thesemay be specialized for the cleavage of particular classes ofMolecular Cell 45, 303CRISPR repeat and/or may interact differently
with the multiple CASCADE and CMR com-
plexes in this organism. Another possibility is
that differences in the removal of the repeat-
derived sequence 30 of the spacer by an
unknown nuclease after Cas6 processing (Hale
et al., 2009) influence incorporation efficiency.The extreme variation in crRNA sequence numbers obtained
from adjacent spacers in all the CRISPR arrays was also unex-
pected. In some cases, this is probably explained by the pres-
ence of internal promoter sequences encoded by adjacent
spacers, driving higher transcript levels for particular regions of
crRNA. Another variable that could influence crRNA processing
is the potential for the formation of stable folded RNA structures
following transcription that could influence crRNA processing by
Cas6 and loading into the CMR complex. Each spacer has
a unique sequence that confers a particular capacity to fold on
the local crRNA structure. To address this further, we analyzed
the thermodynamic stability of folded RNA structures for each
crRNA derived from CRISPR locus C and plotted these against
the frequency of occurrence of each crRNA in the CMR
sequencing sample (Figure S2). The crRNAs with the potential
to fold into themost stable structures were clearly not highly rep-
resented in the data set, while the most highly represented
sequences had similar, modest folding propensity. This is
suggestive of an influence of the secondary structure of the
crRNA locally on the efficiency of cleavage by Cas6 and possibly
on the loading of crRNA into the CMR complex. Such effects
may be ameliorated in the thermophiles by the high growth
temperature, but could constitute a significant problem in
temperature mesophiles. In organisms such as E. coli, the repeat
sequence is palindromic, folding into a stable hairpin structure
that is recognized by the CasE nuclease (Brouns et al., 2008).
This may be an evolutionary mechanism that helps impose an–313, February 10, 2012 ª2012 Elsevier Inc. 309
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due to folding of spacer sequences. In contrast, Cas6, which is
present in many thermophiles, binds unstructured crRNA
repeats (Wang et al., 2011).
Structure of the CMR Complex
The EM envelope of the Cmr2/Cmr3/Cmr7 subcomplex bears
some similarity to the clamp region of RNA polymerase. In partic-
ular, the distance between the two sides of the ‘‘claw’’ is 30 A˚
wide, and their length is 40 A˚. It is tempting to view this feature
as a dsRNA binding cleft, particularly as Cmr2 is assumed to
harbor the active site of the CMR complex. In support of this,
the cleft is somewhat deeper in the Cmr2/Cmr3/Cmr7 subcom-
plex, which contains no bound crRNA, in comparison to the full
complex. The lack of crRNA in the Cmr2/Cmr3/Cmr7 subcom-
plex fits with a presumed role for the RAMP-containing Cmr
subunits (Cmr1, Cmr4, and Cmr6) in RNA binding (Makarova
et al., 2011a). This is consistent with the recent prediction that
Cmr3 is most closely related to the Cas5 subunit of CASCADE,
while Cmr1, Cmr4, and Cmr6 are closer matches to the Cas7
subunit (CasC inE. coli), which is known tobindcrRNA (Makarova
et al., 2011a). Compared to Cmr2/Cmr3/Cmr7, the additional
Cmr subunits are distributedmainly at the front and at the bottom
of the complete CMR complex and may form a structure related
to the crRNAbindingCasCbackbone of CASCADE. Visualization
of the path of RNA in theCMR structure remains a key aim to help
elucidate the mechanism and molecular organization.
The Mechanism of SsoCMR in Viral RNA Cleavage
We have demonstrated that the SsoCMR complex cleaves
target RNA in a sequence-specific manner that is dependent
on the presence of a guide crRNA with a cognate sequence
and an 8 nt repeat-derived tag at the 50 end. Cleavage occurs
at UA dinucleotides, generating products with 30-OH and
50-phosphate ends, like those produced by Argonaute and Piwi
(Hutvagner and Simard, 2008). The cleavage sequence is
extremely common in the Sulfolobales and their viruses. Of the
>400 spacers in the CRISPR loci of the S. solfataricus P2
genome, only 11 lack a UA dinucleotide. The palindromic nature
of this dinucleotide ensures that an equivalent UA sequence is
always present in the guide RNA. Cleavage of both the target
and guide RNA at UA sites was observed, with the guide cleaved
significantly more slowly at high ratios of target:substrate. Under
these conditions, one guide RNA molecule could support the
cleavage of several target RNAs, demonstrating that cleavage
of the guide is not essential for target RNA destruction.
Although not yet shown directly, the N-terminal permuted
HD nuclease domain present in Cmr2 is generally assumed to
be the nuclease site of the CMR complex. The distantly related
HD domain present in Cas3 has been shown capable of cleaving
both RNA and DNA, although they are specific for single-
stranded nucleic acids and generate products with 30-cyclic
phosphates (Mulepati and Bailey, 2011; Beloglazova et al.,
2011). It is also possible that the RNA cleavage activity resides
elsewhere in the Cmr2 subunit or in one or more of the
RAMP-containing subunits (Cmr1, Cmr2, Cmr4, and Cmr6),
which are distantly related to Cas5, Cas6, and Cas7 (Makarova
et al., 2011a).310 Molecular Cell 45, 303–313, February 10, 2012 ª2012 Elsevier InWe observed no requirement for a PAM sequence adjacent to
the protospacer in RNA targets. This is a marked difference from
the DNA targeting CASCADE in archaea, which only cleaves
substrates containing a PAM (Gudbergsdottir et al., 2011;
Manica et al., 2011). The primary role of the PAM may be to
maintain a mismatched region between the 50 tag of the crRNA
and the sequence immediately adjacent to the spacer of the
target. For DNA targeting systems, this ensures that the chro-
mosomal CRISPR locus is not targeted for cleavage (Marraffini
and Sontheimer, 2010b; Mojica et al., 2009). Given that the
CMR complex only targets viral RNA, there is no requirement
for PAM detection to operate in this case, as the host genome
will not be a target. Although no PAM is required, CMR-mediated
cleavage requires an unpaired RNA region at the 30 end of
the target RNA, downstream of the protospacer. This discrimina-
tion may be at the structural rather than sequence level and is
consistent with a role in vivo in targeting viral mRNA sequences,
which will typically be considerably longer than the guide RNA
species.
The observed activity of SsoCMR differs markedly from that
reported previously for the enzyme from P. furiosus (Hale et al.,
2009). PfuCMR operates by a molecular ruler mechanism
without sequence-dependent cleavage, generates 30-cyclic
phosphate products, and does not require an extension at the
30 end of the target RNA, at least in vitro. The long evolutionary
distance between the two species may explain these differ-
ences. CMR complexes have been classified into five families
(A–E) on the basis of the sequence of the large subunit, Cmr2
(Garrett et al., 2011). On this basis, the SsoCMR complex
belongs to family B while PfuCMR is one of the very few repre-
sentatives of family C. To put these differences in context, the
type IIIA, CMR-like complex from Staphylococcus epidermidis
targets DNA rather than RNA (Marraffini and Sontheimer,
2008). This may therefore reflect the plasticity inherent in the
CRISPR system.
The RNA targeting functionality of the CMR complex in
prokaryotes has parallels with the eukaryal piRNA pathway
that uses guide RNA to recognize and cleave the mRNA of
mobile genetic elements (Aravin et al., 2007). As in the CRISPR
system, in the piRNA pathway, the small guide RNAs are gener-
ated by cleavage of a long mRNA transcript, loaded into an
endoribonuclease (Piwi), and used to target and degrade the
mobile mRNA by means of dsRNA cleavage, yielding products
with 30-OH termini (reviewed in Nowotny and Yang, 2009). There
are, though, important differences. Piwi recognizes the 50 phos-
phate of the guide RNA specifically (Ma et al., 2005; Parker et al.,
2005), while the guide RNA generated by Cas6 and utilized by
CMR lacks a 50 phosphate and has an essential 8 nt 50 tag.
More fundamentally, there is no obvious homology between
the Piwi and CMR proteins. Piwi uses an RNaseH domain for
dsRNA cleavage, which is absent from the CMR complex. The
stimulation of CMR cleavage activity by ATP suggests that an
ATP-driven conformational change may be utilized to reposition
the dsRNA with respect to the active site. In the absence of
any detectable Walker A or B motifs, the likely site for ATP
binding is the C-terminal polymerase/cyclase domain of Cmr2.
This domain has no known function but is expected to bind
nucleotide triphosphates. If such an ATP-dependent RNAc.
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another aspect of the CMR complex.
Concluding Remarks
In summary, we provide a low-resolution structure of the
CMR complex for prokaryotic viral RNA degradation. Deep
sequencing suggests that posttranscriptional processing may
exert considerable influence on the loading of its crRNA compo-
nent. The reaction mechanism involves manganese-dependent
and ATP-stimulated ribonuclease activity that degrades both
target and guide RNA in a sequence-dependent manner. Future
studies will aim in particular to map the individual subunits within
the EM envelope and the course of the bound crRNA in the
complex and to define the function of the polymerase/cyclase
domain and the role of ATP in the reaction.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of Cmr7 Paralogs
Details of cloning, purification, and crystal structure solution for Sso1986 were
reported previously (Oke et al., 2010). Sso1725 was expressed and purified
according to published protocols (Oke et al., 2010). Briefly, full-length
sso1725 was cloned into the pDEST14 vector with an N-terminal 6xHis tag
and overexpressed in C43 (DE3) E. coli at 37C in LB medium. Expression
was induced using 0.4 mM IPTG, and the cultures were harvested after over-
night incubation at 25C. The cell pellets were resuspended and lysed (Soni-
prep 150, MSE). The lysate was clarified by centrifugation, and then protein
was purified by immobilized nickel affinity chromatography and size-exclusion
chromatography (Superdex 75 column, GE Healthcare). Sso1725 was
concentrated to 10 mg.ml1 for crystallization.
Antibody Generation
Sheep polyclonal antibodies were raised against the recombinant Cmr7
(Sso1986) protein and supplied by the Scottish National Blood Transfusion
Service, Pentlands Science Park, Midlothian.
RNA Oligonucleotides Used for CMR Activity Assays
RNA oligonucleotides were chemically synthesized (Integrated DNA Technol-
ogies), end labeled with 32P-ATP, and purified by denaturing gel electropho-
resis. The sequences used are listed in the Supplemental Experimental
Procedures.
Purification of the Native CMR Complex from S. solfataricus
S. solfataricus strain P2 biomass was grown as described previously (Go¨tz
et al., 2007). TheCMR complex was purified over four column chromatography
steps, and purification was followed using an antibody raised against subunit
Cmr7, as described in the Supplemental Experimental Procedures. This
yielded the homogeneous complex shown in Figure 1.
Expression and Purification of Tagged CMR Complex in
S. solfataricus
This was carried out as described previously by cloning the relevant gene into
entry vector pMZ1 (Zolghadr et al., 2007), followed by subcloning into expres-
sion vector pSVA9, expressing the relevant subunit with a C-terminal strep-His
tag (Albers et al., 2006), described in detail in the Supplemental Experimental
Procedures. The Cmr2/Cmr3/Cmr7 subcomplex analyzed by electron micros-
copy was obtained during purification of the CMR complex with a tagged
Cmr3 subunit. The subcomplex eluted separately from the full complex on
gel filtration and contained no bound crRNA (Figure S5).
RNA Isolation and Sequencing
RNA was extracted from the purified native CMR complex by the classical
phenol/chloroform method followed by ethanol precipitation and vacuum
desiccation. Dried RNA was resuspended in 5 ml water and directly labeledMolein a 10 ml reaction containing polynucleotide kinase and 2 mCi g32P-ATP.
Labeled RNAs were analyzed by electrophoresis on a 15% acrylamide, 7 M
urea, TBE denaturing gel and visualized by phosphorimaging. For crRNA
deep sequencing, small RNA sequences were generated by the GenePool
at the University of Edinburgh using the Illumina small RNA prep kit v1 and sub-
jected to high-throughput sequencing using a Genome Analyzer IIx. This re-
sulted in the addition of the adaptor sequence TCGTATGCCGTCTTCTGCTTG
at the 30 end of each sequence. The adaptor sequencewas trimmed away from
the reads with a bespoke Perl script. Reads were mapped against the S. solfa-
taricus P2 genome with BWA (Li and Durbin, 2009) using default parameters
and converted into BAM using SAMtools (Li et al., 2009). Of the 2,527,217
reads, 1,997,151 were mapped (79%). The number and strand orientation of
the reads mapping to each spacer were quantified. The raw data from
the sequencing run is available from the corresponding author on request,
and the sequences mapping onto each spacer are listed in Table S1.
The raw sequence data have been uploaded to the Sequence Read Archive
with accession number ERP001053 (http://www.ebi.ac.uk/ena/data/view/
ERP001053).
RNA Cleavage Assays
Purified SsoCMR complex and unlabeled guide RNA were mixed in buffer
(20 mM Mes$HCl [pH 6.0], 100 mM potassium glutamate, 10 mM DTT,
10 mM MnCl2, and the RNase inhibitor SUPERase.In [Ambion]) and preincu-
bated at room temperature for 10 min prior to the addition of 50-32P-end-
labeled synthetic target RNA to the reaction mix. Target and guide RNA and
CMR complex concentrations are indicated in the figure legends. The reaction
was further incubated at 75C for 10 min in standard assays or for the time
indicated in the figure. Reactions were stopped by chilling on ice and addition
of formamide loading buffer. Samples were separated on 20% polyacryl-
amide, 7 M urea, 13 TBE gels. Electrophoresis was completed at 90 W,
50C for 90 min, and the gels were visualized by phosphorimaging. 50 end-
labeled RNA size standards (Decade Markers, Ambion) were used to
determine the sizes of the observed products. Cas6 activity was assayed as
described previously (Lintner et al., 2011).
Crystallography of Sso1725
Sso1725 crystals were grown at 20C using the sitting drop vapor diffusion
method. A reservoir of 0.15 M sodium acetate (pH 5.6), 2.0 M ammonium
sulfate was used, and protein was mixed with the precipitant at a ratio of
2:1. Crystals were cryoprotected by successively soaking in solutions of reser-
voir containing 8%, 16%, 20%, and 25% glycerol before freezing in liquid
nitrogen. A native data set at 2.08 A˚ resolution was collected at Diamond Light
Source (Beamline I03). An anomalous SAD data set was collected at the same
beamline using a native crystal briefly soaked in reservoir solution containing
42 mM samarium chloride before cryoprotecting as described above. Data
sets were processed and refined using the methods described in the Supple-
mental Experimental Procedures. The coordinates were deposited in the PDB
under the accession code 2XVO.
EM Studies
The intact CMR complex bound to crRNA and the Cmr2/Cmr3/Cmr7 subcom-
plex were studied by negative-staining electron microscopy and single-
particle analysis. Data were collected on an FEI F20 FEG microscope,
equipped with an 8 k 3 8 k CCD camera. Images were collected under low-
dose mode at a magnification of 50,0003, at a final sampling of 1.6 A˚/pixel
at the specimen level. Single-particle images were selected interactively using
the Boxer program from the EMAN single-particle analysis package (Ludtke
et al., 1999) and extracted into boxes. Image processing was performed using
the IMAGIC-5 package (van Heel et al., 1996). The data set was resampled at
6.4 A˚/pixel. 10,235 (CMR/RNA) and 5,612 (Cmr2/Cmr3/Cmr7) images were
band-pass filtered with a high pass cutoff of 110 A˚ and a low pass cutoff of
18 A˚. The single-particle images were analyzed by Multivariate Statistical
Analysis with IMAGIC-5. The data set was subjected to successive rounds
of alignment and classification in order to improve the resulting image class
averages. Selected CMR/RNA class averageswere used to calculate a starting
3D volume by common lines using the Euler program in the IMAGIC-5
package. The CMR/RNA structure was refined until the map converged.cular Cell 45, 303–313, February 10, 2012 ª2012 Elsevier Inc. 311
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Euler angles by projection matching. Subsequent refinement was carried out
until the Cmr2/Cmr3/Cmr7 map converged. Figures were prepared with
UCSF Chimera (Goddard et al., 2007).
ACCESSION NUMBERS
The crystal structure of the Cmr7 subunit of CMR (Sso1725) has been
submitted to the Protein Data Bank with accession number 2X5Q. The deep
sequencing data for the RNA bound to the CMR complex has been uploaded
to the Sequence Read Archive with accession number ERP001053.
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